NovoCure Limited
NASDAQ:NVCR
17.38 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 163.767 | 240.821 | 115.326 | 208.802 | 234.674 | 177.321 | 140.622 | 78.592 | 99.78 | 119.423 | 57.613 | 175.894 |
| Short Term Investments
| 796.106 | 669.795 | 854.099 | 728.898 | 607.902 | 148.769 | 105.256 | 104.719 | 119.854 | 150.001 | 44.999 | 0 |
| Cash and Short Term Investments
| 962.2 | 910.616 | 969.425 | 937.7 | 842.576 | 326.09 | 245.878 | 183.311 | 219.634 | 269.424 | 102.612 | 175.894 |
| Net Receivables
| 102.072 | 77.114 | 86.261 | 93.567 | 96.699 | 58.859 | 36.523 | 29.567 | 6.339 | 0 | 0 | 0 |
| Inventory
| 35.086 | 38.152 | 29.376 | 24.427 | 27.422 | 23.701 | 22.555 | 22.025 | 25.549 | 13.594 | 3.446 | 1.892 |
| Other Current Assets
| 9.544 | 8.527 | 26.467 | 17.832 | 32.744 | 31.297 | 5.665 | 5.016 | 2.505 | 10.886 | 5.772 | 5.697 |
| Total Current Assets
| 1,106.575 | 1,034.409 | 1,111.529 | 1,073.526 | 999.441 | 439.947 | 321.369 | 245.134 | 261.873 | 293.904 | 111.83 | 183.483 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 119.591 | 97.698 | 68.958 | 53.883 | 41.634 | 34.597 | 15.366 | 18.067 | 18.62 | 12.581 | 5.749 | 5.176 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 14.618 | 14.022 | 11.161 | 12.086 | 10.908 | 4.904 | 3.058 | 2.097 | 1.588 | 0.851 | 0.297 | 0.252 |
| Total Non-Current Assets
| 134.209 | 111.72 | 80.119 | 65.969 | 52.542 | 39.501 | 18.424 | 20.164 | 20.208 | 13.432 | 6.046 | 5.428 |
| Total Assets
| 1,240.784 | 1,146.129 | 1,191.648 | 1,139.495 | 1,051.983 | 479.448 | 339.793 | 265.298 | 282.081 | 307.336 | 117.876 | 188.911 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 105.086 | 94.391 | 85.197 | 72.6 | 53.647 | 36.925 | 26.708 | 17.206 | 18.356 | 13.905 | 10.033 | 10.286 |
| Short Term Debt
| 566.083 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 9.134 | 8.66 | 5.797 | 5.34 | 12.011 | 12.263 | 9.11 | 3.142 | 2.85 | 0.693 | 0.384 |
| Deferred Revenue
| 14.225 | 16.224 | 18.028 | 17.762 | 17.765 | 11.773 | 8.84 | 4.959 | 2.267 | 0 | 0 | 0 |
| Other Current Liabilities
| 70.982 | 59.366 | 46.892 | 46.443 | 36.86 | 25.602 | 16.749 | 18.927 | 13.117 | 11.872 | 6.943 | 4.928 |
| Total Current Liabilities
| 756.376 | 179.115 | 158.777 | 142.602 | 113.612 | 86.311 | 64.56 | 50.202 | 36.882 | 28.627 | 17.669 | 15.598 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 117.271 | 596.242 | 584.271 | 575.213 | 444.198 | 163.564 | 149.268 | 97.342 | 96.231 | 23.097 | 0.321 | 0.346 |
| Deferred Revenue Non-Current
| 0 | 0 | 2.878 | 6.477 | 12.139 | 7.807 | 9.929 | 0 | 0.906 | 0.785 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 4.543 | 5.171 | 3.754 | 0.124 | 0 | -0.906 | -0.785 | 0 | 0 |
| Other Non-Current Liabilities
| 6.958 | 8.276 | 4.552 | 4.709 | 5.508 | 3.976 | 3.653 | 4.19 | 6.623 | 4.792 | 2.011 | 1.188 |
| Total Non-Current Liabilities
| 124.229 | 604.518 | 591.701 | 586.399 | 461.845 | 175.347 | 162.974 | 101.532 | 102.854 | 27.889 | 2.332 | 1.534 |
| Total Liabilities
| 880.605 | 783.633 | 750.478 | 729.001 | 575.457 | 261.658 | 227.534 | 151.734 | 139.736 | 56.516 | 20.001 | 17.132 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -1,154.13 | -985.503 | -778.46 | -685.926 | -631.077 | -650.885 | -643.655 | -582.258 | -519.926 | -388.081 | -276.5 | -195.818 |
| Accumulated Other Comprehensive Income/Loss
| -5.5 | -5.469 | -2.433 | -3.169 | -3.832 | -2.767 | -1.4 | -1.343 | -1.883 | -1.505 | -4.276 | -2.414 |
| Other Total Stockholders Equity
| 1,519.809 | 1,353.468 | 1,222.063 | 1,099.589 | 1,111.435 | 871.442 | 757.314 | 697.165 | 664.154 | 640.406 | 374.375 | 367.597 |
| Total Shareholders Equity
| 360.179 | 362.496 | 441.17 | 410.494 | 476.526 | 217.79 | 112.259 | 113.564 | 142.345 | 250.82 | 97.875 | 171.779 |
| Total Equity
| 360.179 | 362.496 | 441.17 | 410.494 | 476.526 | 217.79 | 112.259 | 113.564 | 142.345 | 250.82 | 97.875 | 171.779 |
| Total Liabilities & Shareholders Equity
| 1,240.784 | 1,146.129 | 1,191.648 | 1,139.495 | 1,051.983 | 479.448 | 339.793 | 265.298 | 282.081 | 307.336 | 117.876 | 188.911 |